2005P-0411 | Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs | |||||||||||||||||||||||
FDA Comment Number : | EC426 | |||||||||||||||||||||||
Submitter : | Ms. Kathryn Carr | Date & Time: | 01/26/2006 06:01:21 | |||||||||||||||||||||
Organization : | Ms. Kathryn Carr | |||||||||||||||||||||||
Category : | Individual Consumer | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
No entity should dictate a lessening of choice particular to the consumer, especially when it is understood that natural substances are not harmful like synthetics can be. If this is to be a democracy and open market-consumer economy then we should have THE OPTION to BUY WHAT WE KNOW IS GOOD/BETTER FOR US! | ||||||||||||||||||||||||